Find a clinical trial

Search by keyword
Phases
Recruitment Status
Indications
Reset


Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs


Phase: Phase III Trial

Status: Recruiting

Indication: Gastroenteropancreatic Neuroendocrine Tumor

A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.


Phase: Phase IV Trial

Status: Not Yet recruiting

Indication: Upper Limb Spasticity

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines


Phase: Phase I/II Trial

Status: Recruiting

Indication: Moderate to Severe Upper Facial Lines

An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France


Phase: Phase II Trial

Status: Active, not recruiting

Indication: Fibrodysplasia Ossificans Progressiva


The list above displays information about clinical trials sponsored by Ipsen.

Only interventional studies that are not yet recruiting, recruiting, active not recruiting or completed since 2015 will be displayed.

The study results will be available on clintrial.gov from 12 months after the end of the study.

To learn more about available studies, go on: https://clinicaltrials.gov/.

Last updated date: 07/29/2021


© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2021